ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,619,212 | +269.7% | 1,037,282 | +318.3% | 0.22% | +263.3% |
| Q2 2023 | $5,036,880 | -79.7% | 248,000 | -79.4% | 0.06% | -81.9% |
| Q4 2022 | $24,839,782 | +201.1% | 1,201,150 | +359.5% | 0.33% | +147.8% |
| Q1 2022 | $8,250,000 | -88.1% | 261,419 | -84.7% | 0.13% | -86.5% |
| Q4 2021 | $69,059,000 | +16.6% | 1,706,425 | +0.4% | 0.99% | +2.3% |
| Q3 2021 | $59,248,000 | +29.7% | 1,699,113 | +2.1% | 0.97% | +13.5% |
| Q2 2021 | $45,682,000 | +31.4% | 1,663,568 | +34.4% | 0.85% | +10.5% |
| Q1 2021 | $34,755,000 | +2442.4% | 1,237,730 | +1156.4% | 0.77% | +686.7% |
| Q1 2020 | $1,367,000 | – | 98,516 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |